Provention Bio secures FDA approval for TZIELD to delay diabetes
TZIELD is an anti-CD3-directed antibody, indicated for administration as a once-daily intravenous infusion for 14 days, to delay…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Nov 22
TZIELD is an anti-CD3-directed antibody, indicated for administration as a once-daily intravenous infusion for 14 days, to delay…
17 Nov 22
Zolbetuximab is an investigational monoclonal antibody that targets Claudin 18.2 and is used for the treatment of CLDN18.2-positive,…
16 Nov 22
"Whether elevating special gatherings like holiday parties or gifting moments with family and friends, Ferrero Rocher is the…
16 Nov 22
To determine which foods should be included on the FTL, the FDA developed a risk-ranking model for food…
15 Nov 22
The company will initiate a post-approval efficacy study in areas with active chikungunya virus (CHIKV) transmission, in collaboration…
14 Nov 22
The FDA approval is supported by positive results from the Phase 3 POSEIDON study, which showed a significant…
14 Nov 22
The mRNA manufacturing plant is expected to create regional manufacturing capacities to support BioNTech’s pipeline of mRNA-based vaccines…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 Nov 22
VidPrevtyn Beta is a monovalent, recombinant-protein, next-generation Covid-19 vaccine developed by Sanofi, leveraging GSK’s pandemic adjuvant, and is…
11 Nov 22
The authorisation was based on findings of the SAVE-MORE phase 3 study which showed long-term benefits with improved…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Nov 22
The British health regulator has expanded the conditional marketing authorisation (CMA) for Novavax’s Nuvaxovid as a booster dose…